 statistically significant (P < .000) in favor of efinaconazole topical solution 00%. In Study 0, 00.0% of subjects treated with efinaconazole demonstrated mycologic cure compared to only 00.0% of subjects treated with vehicle. In Study 0, 00.0% of subjects treated with efinaconazole demonstrated mycologic cure compared to only 00.0% of subjects treated with vehicle. 